Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
GILD has been in the news recently: Gilead Sciences, Inc. (GILD) will announce its second-quarter earnings results on August 7, 2025, after the market closes. The company also updated its annual outlook following the earnings announcement.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
